Here are takeaways from the company’s fourth quarter.
1. Orthofix’s net sales hit $116.9 million, reflecting a 7.7 percent increase compared to 2016.
2. The net income from continuing operations reached $1.5 million, compared to a net loss of $5.1 million in 2016.
3. The company’s adjusted EBITDA was $24.3 million, a 15.1 percent boost from 2016.
4. The spine fixation line saw net sales of $16.9 million, a 10.7 percent jump from the same period the year prior.
The full-year 2017 results are as follows.
5. Net sales reached $433.8 million, a 5.9 percent increased compared to 2016.
6. Net income from continuing operations reached $7.3 million, reflecting a $3.8 million jump compared to the year prior.
7. The adjusted EBITDA was $81.6 million, a 2.9 percent increase compared to 2016.
8. The spine fixation segment reached net sales of nearly $82 million, an 8.3 percent jump from 2016.
More articles on devices:
Where Medtronic is headed: 5 quotes from the Q3 conference call
K2M, International Spine Study Group Foundation join forces for spine data collection — 5 things to know
Who’s leading the global spine surgery device market?
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
